NanoViricides to Present Antiviral Pipeline at PODD 2025 Conference
October 27, 2025 — NanoViricides presents antiviral pipeline at PODD 2025. Lead candidate NV-387 advances to Phase II trials for MPox & respiratory infections. Broad-spectrum nanoviricide technology targets multiple viruses.